Pfizer's chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.
President Trump has repeatedly compared his efforts to end the war in Iran to President Obama's 2016 deal, while also criticizing Obama for his handling of …
As policymakers reconsider the scope of birthright citizenship, Puerto Rico exemplifies how territorial ambiguity can obscure constitutional lines and complicate national policy.
China is now a peer competitor in drug innovation — and it intends to stay that way on its own terms, writes Dennis Kwok.
The technology identifies patterns in the pancreas that are invisible to the human eye